Home » Topics » Regulatory » EMA

EMA
RSS

Xilonix will undergo accelerated assessment in E.U.

April 4, 2016

CHMP recommends approval of Strimvelis for ADA-SCID

April 4, 2016

Samsung Bioepis' infliximab biosimilar receives positive opinion in E.U.

April 4, 2016

EMA's CHMP backs approval of Trevicta for schizophrenia

April 4, 2016

Amicus' migalastat gets positive opinion from EMA for Fabry disease

April 4, 2016

EMA's COMP backs orphan drug designation for CDNF in ALS

March 31, 2016

Coagadex receives approval in Europe

March 31, 2016

Ubenimex awarded orphan drug designation in E.U. for PAH

March 29, 2016

EMA approves centralized review of Pulmaquin

March 18, 2016

Regulatory agencies review Zydelig over serious adverse events in ongoing trials

March 16, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...